Have you been wondering what OIG has done regarding drug pricing and reimbursement since 2010? Today, OIG has made it easier to find out, posting a Drug Pricing and Reimbursement Web portfolio on its website. According to an OIG announcement, the portfolio “pulls together the HHS OIG’s body of work since 2010 as well as other relevant items that relate to drug pricing and reimbursement in HHS programs. The portfolio features planned work, completed reports, industry guidance, and enforcement actions.”
The Arent Fox LLP Health Care Group regularly monitors OIG developments and the pharmaceutical market. If you would like to discuss this or any other related matter, please contact Stephanie Trunk or Erin Atkins in the Washington, D.C. office or the Arent Fox professional that regularly handles your matters.